Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 28 Sept 2022 for Nautilus Biotechnology, Inc., €21k. Read the official filing
Filing timeline
BuySaleSubramanian Sankar
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Closed purchases
Market purchases
2
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Subramanian Sankar: trading record in brief
This profile gathers the share dealings of Subramanian Sankar in Nautilus Biotechnology, Inc. Over a trading history stretching from 15 September 2022 to 26 September 2022, the count stands at 2 filings.
Every open-market trade on record is a purchase: 2 purchases worth €109k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The newest entry dates from 28 September 2022: an open-market purchase of €21k, in Nautilus Biotechnology, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Subramanian Sankar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
10,000 shares@ US$2.02519.3% of flowCommon StockSEC:0001808805-22-000101:0
Canonical exit: 25 Dec 2022 (T+90)
40,000 shares@ US$2.193880.7% of flowCommon StockSEC:0001808805-22-000097:0
Canonical exit: 14 Dec 2022 (T+90)
2 of 2 declarations
